Login to Your Account

Cell Therapy Risk-Reduced? Reneuron Lands $50.7M

By Nuala Moran
Staff Writer

Wednesday, July 24, 2013

LONDON – Stem cell therapy specialist Reneuron plc has raised £33 million (US$50.7 million), including a placing to bring in £23.35 million and a £7.8 million grant from the Welsh Government, in a financing package that will enable the company to build its own manufacturing facility and take three lead programs through to proof of efficacy in Phase II.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription